LANL Scientist Robert Atcher Named SNMMI Fellow

LANL Scientist Dr. Robert Atcher

LANL News:

The Society of Nuclear Medicine and Molecular Imaging has announced the creation of an SNMMI Fellowship recognizing distinguished service to SNMMI as well as exceptional achievement in the field of nuclear medicine and molecular imaging at its 2016 Annual Meeting, June 11-15 in San Diego, Calif.

Robert  Atcher, PhD, MBA, a communication specialist in the Community and Public Affairs Division at Los Alamos National Laboratory (LANL) and the UNM/LANL Professor of Pharmacy in the College of Pharmacy at the University of New Mexico is among the 35 new SNMMI Fellows. A past president of the Society of Nuclear Medicine (now SNMMI), Atcher has been at Los Alamos for 19 years. His research focuses on the development of radiopharmaceuticals for the diagnosis and treatment of cancer. Atcher has published 100 papers in peer reviewed journals, holds eight patents, presented more than 80 papers at national and international meetings, and given more than 150 invited talks.

He also is a member of the UNM Comprehensive Cancer Center and currently serves as president of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging. A Fellow of the American Institute of Chemists, Atcher is a member of the American Chemical Society, the American Society for Radiation Oncology and the Society of Radiopharmaceutical Sciences.

Selection of SNMMI Fellows is based on documented excellence in volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation; educational efforts in nuclear medicine and molecular imaging; or clinical practice of nuclear medicine and molecular imaging. SNMMI Fellowship will be recognized with the designation FSNMMI. 

About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), based in Reston, Va., is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.

SNMMI’s more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit